Cohort of Cord Blood Bank

NCT ID: NCT07249099

Last Updated: 2025-11-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ENROLLING_BY_INVITATION

Total Enrollment

2000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-03-25

Study Completion Date

2030-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this observational study was to establish a cohort of umbilical cord blood stored in Tianjin Cord Blood Bank.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is an observational study. It is planned to observe the incidence and death of common chronic non-communicable diseases, rare diseases and key diseases through follow-up of environmental exposure in the early life of the study population and investigation of adverse lifestyle of mothers during pregnancy, and explore the influence of factors including genetics, environment and lifestyle on the occurrence, development and prognosis of the diseases concerned.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Health Status Childhood Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Voluntarily participated in this study and provided signed informed consent forms.
* People stored umbilical cord blood in Tianjin Cord Blood Bank.
* The information registered at the time of storage is complete and the contact details are genuine and available.

Exclusion Criteria

* Refusing to answer the researcher's phone or refusing to accept the investigation.
* People who are unable or unsuitable to participate in the study for various other reasons .
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Institute of Hematology & Blood Diseases Hospital, China

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Institute of Hematology & Blood Diseases Hospital

Tianjin, Tianjin Municipality, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

QTJC2025029

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.